Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Hypertension (Dallas, Tex. : 1979)|February 1, 1992
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal ratsY X Wang, I Gavras, T Wierzba, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Clinical application of orally active angiotensin converting enzyme inhibitorsH Gavras, J Biollaz, B Waeber, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Models of experimental hypertension in miceC Johns, I Gavras, D E Handy, et al.
Transactions of the Association of American Physicians|January 1, 1978
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
American Journal of Hypertension|September 30, 1998
Renal artery clipping attenuates the progression of adriamycin nephropathyA L Balbi, R J Franco, P Barretti, et al.
Circulation Research|February 17, 2001
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertensionI Duka, E Kintsurashvili, I Gavras, et al.
Journal of Clinical Pharmacology|February 1, 1981
Effect of pindolol on blood pressure, plasma renin activity, and catecholamines in hypertensive patientsI Gavras, H Gavras, C P Tifft, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
Clinical Therapeutics|May 1, 1994
Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazeprilM Bursztyn, I Gavras, L Gourley, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Hypertension (Dallas, Tex. : 1979)|February 1, 1992
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal ratsY X Wang, I Gavras, T Wierzba, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Clinical application of orally active angiotensin converting enzyme inhibitorsH Gavras, J Biollaz, B Waeber, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Models of experimental hypertension in miceC Johns, I Gavras, D E Handy, et al.
Transactions of the Association of American Physicians|January 1, 1978
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
American Journal of Hypertension|September 30, 1998
Renal artery clipping attenuates the progression of adriamycin nephropathyA L Balbi, R J Franco, P Barretti, et al.
Circulation Research|February 17, 2001
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertensionI Duka, E Kintsurashvili, I Gavras, et al.
Journal of Clinical Pharmacology|February 1, 1981
Effect of pindolol on blood pressure, plasma renin activity, and catecholamines in hypertensive patientsI Gavras, H Gavras, C P Tifft, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
Clinical Therapeutics|May 1, 1994
Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazeprilM Bursztyn, I Gavras, L Gourley, et al.
Pageof 17